Top Medical News
15 minutes ago
To make an accurate diagnosis and treatment plan for patients with chronic normotensive hypokalemia, it is important to include an integrated interpretation of the urine sodium (Na+) and chloride (Cl−) excretion and their ratio apart from body mass index (BMI), sex and blood acid-base status, suggests a recent study.
Tristan Manalac, 22 hours ago
Excessive daytime sleepiness (EDS) is associated with persistent diabetes-related distress (DRD) in a Singaporean population, a new longitudinal study shows.
A prospective association exists between physical activity and cardiometabolic risk in healthy children, a recent study has found.
Stephen Padilla, Yesterday
Maternal overweight and severity of obesity are associated with elevated risks of any major congenital malformations and several subgroups of organ specific malformations in offspring, a population-based cohort study has found.
2 days ago
Women with polycystic ovary syndrome (PCOS) or isolated hirsutism are more likely to experience anxiety or depression symptoms and their coexistence than controls, a recent study has found.
2 days ago
Maintaining lean body weight without central adiposity, following healthy diets and being physically active help significantly reduce the risk of developing type 2 diabetes mellitus (T2DM), a study in a Chinese population has shown.
3 days ago
Menopausal symptoms, such as vasomotor, joint and urinary, are associated with obesity, a recent study has found. Hot flashes are particularly related to higher body mass index (BMI), urinary urgency and vaginal dryness.
Special Reports
05 Apr 2017
At a recent lunch symposium held in conjunction with the 1st Malaysian Advances in Women’s Health Congress 2016, Professor Dr Jamiyah Hassan imparted clinical updates and strategies for the optimization of hormone replacement therapy in menopausal women. Highlights from her presentation are summarized below.
16 Mar 2017
Recently, Dr Peter Lin of the Canadian Heart Research Centre spoke on treatment strategies in the management of dyslipidaemia and T2DM at an AstraZeneca-sponsored continuing medical education event. Highlights of his presentations are summarized below.
20 Jan 2017
At the recent Malaysian Osteoporosis Society 2016 Clinical Practice Guideline (CPG) Meeting held on the 8th of October 2016 at Ibis Styles Ipoh, Dr Hew Fen Lee and Professor Dr Chan Siew Pheng presented clinical guidance on the management of osteoporosis, and discussed whether the benefits of treatment outweigh the risks.
04 Jan 2017
At the Diabetes Asia 2016 Conference organized by the National Diabetes Institute, Professor Jean Claude Mbanya presented the case for why gliclazide modified release (MR; Diamicron® MR, Servier) should be the treatment of choice for early and aggressive control of type 2 diabetes (T2D).
16 Dec 2016
BASALOG – Insulin glargine (rDNA) 100 IU/mL soln for inj (cartridge) – CCM Pharmaceuticals
16 Dec 2016
INVOKANA – Canagliflozin hemihydrate 100 mg and 300 mg FC tab – Johnson & Johnson (Janssen)
Pearl Toh, 07 Dec 2016
Preventing hypertension, diabetes, and obesity, which are the major risk factors for heart failure (HF), by ages 45 and 55 years may lower risks of incident HF and prolong HF-free survival, suggests data from the Cardiovascular Disease Lifetime Risk Pooling Project.
Conference Reports
Audrey Abella, 22 Jun 2017
A single dose of the human glucagon receptor (GCGR) antibody, REMD-477, reduces the amount of insulin necessary and significantly improves glycaemic control in individuals with type 1 diabetes (T1D), according to a study presented at the ADA 2017 in San Diego, California, US.
Elaine Soliven, 22 Jun 2017
Severe obesity in children and adolescents may increase the risk of developing youth-onset diabetes, according to a study presented at the American Diabetes Association’s 77th Scientific Sessions held in San Diego, California, US.
Roshini Claire Anthony, 21 Jun 2017

Insulin degludec had comparable cardiovascular safety and reduced the risk of severe hypoglycaemia compared with insulin glargine U100 in patients with type 2 diabetes and high cardiovascular risk, according to results of the DEVOTE* study.

21 Jun 2017
Podcast: Dr Steven Marso speaks about the cardiovascular safety of insulin degludec vs insulin glargine in patients with type 2 diabetes with high cardiovascular risk.
21 Jun 2017
Podcast: Professor Robert Henry talks about the effects of alirocumab vs usual care in patients with type 2 diabetes and mixed dyslipidemia.
21 Jun 2017
Podcast: Professor Bruce Neal summarizes the key findings of the Canagliflozin Cardiovascular Assessment Study.
21 Jun 2017
Podcast: Dr Carla Greenbaum speaks about the potential clinical impact of identifying individuals at risk of type 1 diabetes.
CME Modules
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!